nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—breast cancer	0.147	1	CbGaD
Budesonide—NR3C1—Fluoxymesterone—breast cancer	0.119	0.398	CbGbCtD
Budesonide—Testolactone—Exemestane—breast cancer	0.0287	0.0745	CrCrCtD
Budesonide—Prednisone—Exemestane—breast cancer	0.0257	0.0667	CrCrCtD
Budesonide—CYP3A4—Exemestane—breast cancer	0.024	0.0801	CbGbCtD
Budesonide—Fluprednidene Acetate—Exemestane—breast cancer	0.0239	0.062	CrCrCtD
Budesonide—Loteprednol—Exemestane—breast cancer	0.0239	0.062	CrCrCtD
Budesonide—Methylprednisolone—Exemestane—breast cancer	0.0223	0.0579	CrCrCtD
Budesonide—Prednisolone—Exemestane—breast cancer	0.0218	0.0567	CrCrCtD
Budesonide—Hydrocortamate—Fluoxymesterone—breast cancer	0.0212	0.0549	CrCrCtD
Budesonide—CYP3A4—Letrozole—breast cancer	0.0204	0.0681	CbGbCtD
Budesonide—Testolactone—Fluoxymesterone—breast cancer	0.0199	0.0517	CrCrCtD
Budesonide—Amcinonide—Fluoxymesterone—breast cancer	0.0183	0.0475	CrCrCtD
Budesonide—CYP3A4—Anastrozole—breast cancer	0.0182	0.0607	CbGbCtD
Budesonide—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0178	0.0463	CrCrCtD
Budesonide—Desoximetasone—Fluoxymesterone—breast cancer	0.017	0.044	CrCrCtD
Budesonide—CYP3A4—Toremifene—breast cancer	0.0167	0.0555	CbGbCtD
Budesonide—Mometasone—Fluoxymesterone—breast cancer	0.0166	0.043	CrCrCtD
Budesonide—Loteprednol—Fluoxymesterone—breast cancer	0.0166	0.043	CrCrCtD
Budesonide—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0166	0.043	CrCrCtD
Budesonide—Fluorometholone—Fluoxymesterone—breast cancer	0.0166	0.043	CrCrCtD
Budesonide—Triamcinolone—Fluoxymesterone—breast cancer	0.0166	0.043	CrCrCtD
Budesonide—Betamethasone—Fluoxymesterone—breast cancer	0.0162	0.042	CrCrCtD
Budesonide—Dexamethasone—Fluoxymesterone—breast cancer	0.0162	0.042	CrCrCtD
Budesonide—CYP3A4—Fulvestrant—breast cancer	0.0155	0.0516	CbGbCtD
Budesonide—Prednisolone—Fluoxymesterone—breast cancer	0.0151	0.0393	CrCrCtD
Budesonide—Hydrocortisone—Fluoxymesterone—breast cancer	0.0145	0.0377	CrCrCtD
Budesonide—CYP3A4—Thiotepa—breast cancer	0.0138	0.046	CbGbCtD
Budesonide—CYP3A4—Ixabepilone—breast cancer	0.0126	0.0421	CbGbCtD
Budesonide—CYP3A4—Lapatinib—breast cancer	0.0122	0.0405	CbGbCtD
Budesonide—CYP3A4—Raloxifene—breast cancer	0.00921	0.0307	CbGbCtD
Budesonide—CYP3A4—Vinorelbine—breast cancer	0.00674	0.0225	CbGbCtD
Budesonide—CYP3A4—Tamoxifen—breast cancer	0.00609	0.0203	CbGbCtD
Budesonide—CYP3A4—Mitoxantrone—breast cancer	0.00594	0.0198	CbGbCtD
Budesonide—CYP3A4—Paclitaxel—breast cancer	0.00474	0.0158	CbGbCtD
Budesonide—CYP3A4—Irinotecan—breast cancer	0.00467	0.0156	CbGbCtD
Budesonide—CYP3A4—Vinblastine—breast cancer	0.00416	0.0138	CbGbCtD
Budesonide—CYP3A4—Docetaxel—breast cancer	0.00343	0.0114	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—breast cancer	0.00255	0.0085	CbGbCtD
Budesonide—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000254	0.113	CrCbGaD
Budesonide—Testolactone—CYP19A1—breast cancer	0.000184	0.082	CrCbGaD
Budesonide—Betamethasone—PGR—breast cancer	0.000105	0.0469	CrCbGaD
Budesonide—Triamcinolone—BCHE—breast cancer	8.79e-05	0.0392	CrCbGaD
Budesonide—Dexamethasone—CYP17A1—breast cancer	8.25e-05	0.0368	CrCbGaD
Budesonide—Clobetasol propionate—CYP1A1—breast cancer	8.25e-05	0.0368	CrCbGaD
Budesonide—Hydrocortisone—SHBG—breast cancer	7.68e-05	0.0342	CrCbGaD
Budesonide—Betamethasone—CYP19A1—breast cancer	7.22e-05	0.0322	CrCbGaD
Budesonide—Hydrocortamate—CYP3A4—breast cancer	6.75e-05	0.0301	CrCbGaD
Budesonide—Dexamethasone—NOS2—breast cancer	6.73e-05	0.03	CrCbGaD
Budesonide—Dexamethasone—PGR—breast cancer	6.12e-05	0.0273	CrCbGaD
Budesonide—Ciclesonide—CYP2D6—breast cancer	5.97e-05	0.0266	CrCbGaD
Budesonide—Dexamethasone—CYP1B1—breast cancer	5.72e-05	0.0255	CrCbGaD
Budesonide—Alclometasone—CYP3A4—breast cancer	5.41e-05	0.0241	CrCbGaD
Budesonide—Hydrocortisone—ABCG2—breast cancer	5.29e-05	0.0236	CrCbGaD
Budesonide—Flunisolide—CYP3A4—breast cancer	5.27e-05	0.0235	CrCbGaD
Budesonide—Paramethasone—CYP3A4—breast cancer	5.2e-05	0.0232	CrCbGaD
Budesonide—Ciclesonide—CYP3A4—breast cancer	5.12e-05	0.0228	CrCbGaD
Budesonide—Fluorometholone—CYP3A4—breast cancer	5.08e-05	0.0226	CrCbGaD
Budesonide—Methylprednisolone—CYP3A4—breast cancer	4.91e-05	0.0219	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	4.7e-05	0.00122	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUN—breast cancer	4.69e-05	0.00122	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	4.65e-05	0.00121	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LEP—breast cancer	4.63e-05	0.0012	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	4.56e-05	0.00119	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	4.54e-05	0.00118	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	4.45e-05	0.00116	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EEF1B2—breast cancer	4.41e-05	0.00115	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NR2F1—breast cancer	4.41e-05	0.00115	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	4.32e-05	0.00112	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	4.26e-05	0.00111	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	4.25e-05	0.0011	CbGpPWpGaD
Budesonide—Dexamethasone—CYP19A1—breast cancer	4.2e-05	0.0187	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	4.17e-05	0.00108	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	4.16e-05	0.00108	CbGpPWpGaD
Budesonide—Triamcinolone—CYP3A4—breast cancer	4.14e-05	0.0184	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	4.13e-05	0.00107	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	4.12e-05	0.00107	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	4.12e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NR2F6—breast cancer	4.1e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HNF4G—breast cancer	4.1e-05	0.00107	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	4.1e-05	0.00106	CbGpPWpGaD
Budesonide—Methylprednisolone—ABCB1—breast cancer	4.09e-05	0.0182	CrCbGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	4.06e-05	0.00106	CbGpPWpGaD
Budesonide—Triamcinolone—PTGS2—breast cancer	4.05e-05	0.0181	CrCbGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	4.05e-05	0.00105	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	4.05e-05	0.00105	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	4.04e-05	0.00105	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	4.01e-05	0.00104	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	4.01e-05	0.00104	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	3.97e-05	0.00103	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	3.97e-05	0.00103	CbGpPWpGaD
Budesonide—Dexamethasone—ABCG2—breast cancer	3.94e-05	0.0176	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	3.91e-05	0.00102	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—RB1—breast cancer	3.86e-05	0.001	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	3.85e-05	0.001	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IGF1—breast cancer	3.82e-05	0.000994	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—RARB—breast cancer	3.8e-05	0.000988	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	3.79e-05	0.000985	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—breast cancer	3.77e-05	0.00098	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	3.76e-05	0.000977	CbGpPWpGaD
Budesonide—Prednisone—CYP3A4—breast cancer	3.75e-05	0.0167	CrCbGaD
Budesonide—NR3C1—Gene Expression—HNRNPL—breast cancer	3.65e-05	0.000949	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MED12—breast cancer	3.65e-05	0.000947	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SERPINE1—breast cancer	3.63e-05	0.000944	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA3—breast cancer	3.54e-05	0.000921	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	3.5e-05	0.000911	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	3.49e-05	0.000908	CbGpPWpGaD
Budesonide—Prednisolone—CYP3A4—breast cancer	3.46e-05	0.0154	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	3.42e-05	0.000888	CbGpPWpGaD
Budesonide—Betamethasone—CYP3A4—breast cancer	3.39e-05	0.0151	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	3.35e-05	0.000872	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	3.34e-05	0.000869	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—breast cancer	3.32e-05	0.0148	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	3.3e-05	0.000858	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	3.29e-05	0.000856	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	3.28e-05	0.000851	CbGpPWpGaD
Budesonide—Prednisone—ALB—breast cancer	3.27e-05	0.0146	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—GSTA4—breast cancer	3.24e-05	0.000842	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	3.23e-05	0.00084	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	3.2e-05	0.000831	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA2—breast cancer	3.16e-05	0.000821	CbGpPWpGaD
Budesonide—Prednisone—ABCB1—breast cancer	3.13e-05	0.0139	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—SULT1A1—breast cancer	3.12e-05	0.000811	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	3.11e-05	0.000809	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—breast cancer	3.1e-05	0.000805	CbGpPWpGaD
Budesonide—Dexamethasone—CYP1A1—breast cancer	3.09e-05	0.0138	CrCbGaD
Budesonide—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	3.08e-05	0.000799	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	3.08e-05	0.000799	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTA1—breast cancer	3.05e-05	0.000792	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PGR—breast cancer	3.02e-05	0.000785	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—NAT2—breast cancer	3.01e-05	0.000783	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF2S2—breast cancer	3.01e-05	0.000782	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	2.97e-05	0.000772	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESRRA—breast cancer	2.92e-05	0.000759	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	2.91e-05	0.000756	CbGpPWpGaD
Budesonide—Prednisolone—ABCB1—breast cancer	2.88e-05	0.0128	CrCbGaD
Budesonide—NR3C1—Adipogenesis—CTNNB1—breast cancer	2.84e-05	0.000737	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—breast cancer	2.83e-05	0.000737	CbGpPWpGaD
Budesonide—Betamethasone—ABCB1—breast cancer	2.82e-05	0.0126	CrCbGaD
Budesonide—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	2.81e-05	0.00073	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	2.81e-05	0.00073	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CDKN1A—breast cancer	2.77e-05	0.00072	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—YBX1—breast cancer	2.77e-05	0.00072	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	2.73e-05	0.000709	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	2.66e-05	0.000691	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	2.66e-05	0.000691	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	2.66e-05	0.00069	CbGpPWpGaD
Budesonide—Hydrocortisone—CYP3A4—breast cancer	2.65e-05	0.0118	CrCbGaD
Budesonide—NR3C1—Gene Expression—EEF2—breast cancer	2.64e-05	0.000686	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—THRB—breast cancer	2.64e-05	0.000686	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	2.55e-05	0.000663	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	2.54e-05	0.000661	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—TET2—breast cancer	2.53e-05	0.000658	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RXRB—breast cancer	2.53e-05	0.000658	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	2.52e-05	0.000655	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	2.5e-05	0.000649	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	2.5e-05	0.000649	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPL31—breast cancer	2.48e-05	0.000645	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT3—breast cancer	2.47e-05	0.000643	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	2.47e-05	0.000642	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—MTR—breast cancer	2.46e-05	0.000638	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	2.45e-05	0.000637	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	2.45e-05	0.000637	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—HPGDS—breast cancer	2.41e-05	0.000626	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—AR—breast cancer	2.35e-05	0.000611	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTT1—breast cancer	2.34e-05	0.000607	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	2.33e-05	0.000605	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS4X—breast cancer	2.32e-05	0.000602	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	2.3e-05	0.000599	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2D6—breast cancer	2.3e-05	0.0102	CrCbGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—breast cancer	2.29e-05	0.000596	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EIF3A—breast cancer	2.28e-05	0.000593	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—DNMT3A—breast cancer	2.25e-05	0.000584	CbGpPWpGaD
Budesonide—Flushing—Epirubicin—breast cancer	2.23e-05	0.000176	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—breast cancer	2.23e-05	0.000176	CcSEcCtD
Budesonide—Vomiting—Fluorouracil—breast cancer	2.23e-05	0.000176	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—breast cancer	2.23e-05	0.000176	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—breast cancer	2.23e-05	0.000176	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—breast cancer	2.23e-05	0.000175	CcSEcCtD
Budesonide—Insomnia—Capecitabine—breast cancer	2.22e-05	0.000175	CcSEcCtD
Budesonide—Rash—Fluorouracil—breast cancer	2.21e-05	0.000174	CcSEcCtD
Budesonide—NR3C1—Gene Expression—ELL—breast cancer	2.21e-05	0.000575	CbGpPWpGaD
Budesonide—Dermatitis—Fluorouracil—breast cancer	2.21e-05	0.000174	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.21e-05	0.000575	CbGpPWpGaD
Budesonide—Pharyngitis—Doxorubicin—breast cancer	2.21e-05	0.000174	CcSEcCtD
Budesonide—Hydrocortisone—ABCB1—breast cancer	2.2e-05	0.00982	CrCbGaD
Budesonide—Paraesthesia—Capecitabine—breast cancer	2.2e-05	0.000174	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—breast cancer	2.2e-05	0.000174	CcSEcCtD
Budesonide—Hypersensitivity—Paclitaxel—breast cancer	2.2e-05	0.000174	CcSEcCtD
Budesonide—Headache—Fluorouracil—breast cancer	2.2e-05	0.000173	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—breast cancer	2.2e-05	0.000173	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—breast cancer	2.19e-05	0.000173	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—breast cancer	2.19e-05	0.000173	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.19e-05	0.000569	CbGpPWpGaD
Budesonide—Gastrointestinal disorder—Docetaxel—breast cancer	2.19e-05	0.000172	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—breast cancer	2.19e-05	0.000172	CcSEcCtD
Budesonide—Dyspnoea—Capecitabine—breast cancer	2.19e-05	0.000172	CcSEcCtD
Budesonide—Fatigue—Docetaxel—breast cancer	2.18e-05	0.000172	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—breast cancer	2.18e-05	0.000172	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—breast cancer	2.18e-05	0.000172	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.18e-05	0.000567	CbGpPWpGaD
Budesonide—Nausea—Mitoxantrone—breast cancer	2.18e-05	0.000172	CcSEcCtD
Budesonide—Nausea—Irinotecan—breast cancer	2.18e-05	0.000172	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—breast cancer	2.17e-05	0.000171	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—breast cancer	2.17e-05	0.000171	CcSEcCtD
Budesonide—Pain—Docetaxel—breast cancer	2.17e-05	0.000171	CcSEcCtD
Budesonide—Constipation—Docetaxel—breast cancer	2.17e-05	0.000171	CcSEcCtD
Budesonide—Back pain—Methotrexate—breast cancer	2.16e-05	0.000171	CcSEcCtD
Budesonide—Dyspepsia—Capecitabine—breast cancer	2.16e-05	0.00017	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	2.16e-05	0.000561	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2D6—breast cancer	2.15e-05	0.000558	CbGpPWpGaD
Budesonide—Visual impairment—Doxorubicin—breast cancer	2.15e-05	0.000169	CcSEcCtD
Budesonide—Asthenia—Paclitaxel—breast cancer	2.15e-05	0.000169	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—TNF—breast cancer	2.14e-05	0.000556	CbGpPWpGaD
Budesonide—Decreased appetite—Capecitabine—breast cancer	2.13e-05	0.000168	CcSEcCtD
Budesonide—Alopecia—Epirubicin—breast cancer	2.13e-05	0.000168	CcSEcCtD
Budesonide—Nausea—Gemcitabine—breast cancer	2.12e-05	0.000167	CcSEcCtD
Budesonide—Gastrointestinal disorder—Capecitabine—breast cancer	2.12e-05	0.000167	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.12e-05	0.00055	CbGpPWpGaD
Budesonide—Fatigue—Capecitabine—breast cancer	2.12e-05	0.000167	CcSEcCtD
Budesonide—Pruritus—Paclitaxel—breast cancer	2.12e-05	0.000167	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	2.12e-05	0.00055	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	2.11e-05	0.000549	CbGpPWpGaD
Budesonide—Vision blurred—Methotrexate—breast cancer	2.11e-05	0.000166	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—breast cancer	2.11e-05	0.000166	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.11e-05	0.000548	CbGpPWpGaD
Budesonide—Pain—Capecitabine—breast cancer	2.1e-05	0.000165	CcSEcCtD
Budesonide—Constipation—Capecitabine—breast cancer	2.1e-05	0.000165	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—breast cancer	2.09e-05	0.000165	CcSEcCtD
Budesonide—Feeling abnormal—Docetaxel—breast cancer	2.09e-05	0.000165	CcSEcCtD
Budesonide—Nausea—Fluorouracil—breast cancer	2.09e-05	0.000164	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—breast cancer	2.08e-05	0.000164	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—breast cancer	2.08e-05	0.000164	CcSEcCtD
Budesonide—Gastrointestinal pain—Docetaxel—breast cancer	2.07e-05	0.000163	CcSEcCtD
Budesonide—Anaemia—Methotrexate—breast cancer	2.07e-05	0.000163	CcSEcCtD
Budesonide—Flushing—Doxorubicin—breast cancer	2.07e-05	0.000163	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—breast cancer	2.07e-05	0.000163	CcSEcCtD
Budesonide—Flatulence—Epirubicin—breast cancer	2.06e-05	0.000163	CcSEcCtD
Budesonide—Tension—Epirubicin—breast cancer	2.06e-05	0.000162	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	2.05e-05	0.000534	CbGpPWpGaD
Budesonide—Dysgeusia—Epirubicin—breast cancer	2.05e-05	0.000162	CcSEcCtD
Budesonide—NR3C1—Gene Expression—PABPC1—breast cancer	2.05e-05	0.000532	CbGpPWpGaD
Budesonide—Diarrhoea—Paclitaxel—breast cancer	2.05e-05	0.000161	CcSEcCtD
Budesonide—Nervousness—Epirubicin—breast cancer	2.03e-05	0.00016	CcSEcCtD
Budesonide—Back pain—Epirubicin—breast cancer	2.03e-05	0.00016	CcSEcCtD
Budesonide—Feeling abnormal—Capecitabine—breast cancer	2.02e-05	0.000159	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—breast cancer	2.02e-05	0.000159	CcSEcCtD
Budesonide—Malaise—Methotrexate—breast cancer	2.02e-05	0.000159	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—breast cancer	2.01e-05	0.000159	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—breast cancer	2.01e-05	0.000158	CcSEcCtD
Budesonide—Vertigo—Methotrexate—breast cancer	2.01e-05	0.000158	CcSEcCtD
Budesonide—Gastrointestinal pain—Capecitabine—breast cancer	2.01e-05	0.000158	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—breast cancer	2.01e-05	0.000158	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—breast cancer	2e-05	0.000158	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—breast cancer	2e-05	0.000158	CcSEcCtD
Budesonide—Dizziness—Paclitaxel—breast cancer	1.98e-05	0.000156	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—breast cancer	1.97e-05	0.000156	CcSEcCtD
Budesonide—Dexamethasone—CYP3A4—breast cancer	1.97e-05	0.00879	CrCbGaD
Budesonide—Alopecia—Doxorubicin—breast cancer	1.97e-05	0.000155	CcSEcCtD
Budesonide—Cough—Methotrexate—breast cancer	1.95e-05	0.000154	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—breast cancer	1.95e-05	0.000154	CcSEcCtD
Budesonide—Urticaria—Capecitabine—breast cancer	1.95e-05	0.000154	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—breast cancer	1.94e-05	0.000153	CcSEcCtD
Budesonide—Body temperature increased—Capecitabine—breast cancer	1.94e-05	0.000153	CcSEcCtD
Budesonide—Abdominal pain—Capecitabine—breast cancer	1.94e-05	0.000153	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—breast cancer	1.94e-05	0.000153	CcSEcCtD
Budesonide—Anaemia—Epirubicin—breast cancer	1.94e-05	0.000153	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—breast cancer	1.93e-05	0.00861	CrCbGaD
Budesonide—Agitation—Epirubicin—breast cancer	1.92e-05	0.000152	CcSEcCtD
Budesonide—NR3C1—Gene Expression—DNMT3B—breast cancer	1.92e-05	0.000499	CbGpPWpGaD
Budesonide—Flatulence—Doxorubicin—breast cancer	1.91e-05	0.00015	CcSEcCtD
Budesonide—Myalgia—Methotrexate—breast cancer	1.91e-05	0.00015	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—breast cancer	1.91e-05	0.00015	CcSEcCtD
Budesonide—Chest pain—Methotrexate—breast cancer	1.91e-05	0.00015	CcSEcCtD
Budesonide—Tension—Doxorubicin—breast cancer	1.9e-05	0.00015	CcSEcCtD
Budesonide—Vomiting—Paclitaxel—breast cancer	1.9e-05	0.00015	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—breast cancer	1.9e-05	0.00015	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.89e-05	0.000149	CcSEcCtD
Budesonide—Malaise—Epirubicin—breast cancer	1.89e-05	0.000149	CcSEcCtD
Budesonide—Rash—Paclitaxel—breast cancer	1.89e-05	0.000149	CcSEcCtD
Budesonide—Dermatitis—Paclitaxel—breast cancer	1.88e-05	0.000148	CcSEcCtD
Budesonide—Discomfort—Methotrexate—breast cancer	1.88e-05	0.000148	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—breast cancer	1.88e-05	0.000148	CcSEcCtD
Budesonide—NR3C1—Gene Expression—RPL23A—breast cancer	1.88e-05	0.000489	CbGpPWpGaD
Budesonide—Vertigo—Epirubicin—breast cancer	1.88e-05	0.000148	CcSEcCtD
Budesonide—Syncope—Epirubicin—breast cancer	1.88e-05	0.000148	CcSEcCtD
Budesonide—Back pain—Doxorubicin—breast cancer	1.87e-05	0.000148	CcSEcCtD
Budesonide—Headache—Paclitaxel—breast cancer	1.87e-05	0.000148	CcSEcCtD
Budesonide—Hypersensitivity—Docetaxel—breast cancer	1.87e-05	0.000147	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—breast cancer	1.86e-05	0.000147	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.86e-05	0.000484	CbGpPWpGaD
Budesonide—Palpitations—Epirubicin—breast cancer	1.85e-05	0.000146	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	1.85e-05	0.000481	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	1.85e-05	0.00048	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	1.85e-05	0.00048	CbGpPWpGaD
Budesonide—Confusional state—Methotrexate—breast cancer	1.84e-05	0.000145	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—breast cancer	1.84e-05	0.000145	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.84e-05	0.000477	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RARB—breast cancer	1.83e-05	0.000476	CbGpPWpGaD
Budesonide—Cough—Epirubicin—breast cancer	1.83e-05	0.000144	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—breast cancer	1.83e-05	0.000144	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—breast cancer	1.83e-05	0.000144	CcSEcCtD
Budesonide—Asthenia—Docetaxel—breast cancer	1.82e-05	0.000143	CcSEcCtD
Budesonide—Infection—Methotrexate—breast cancer	1.81e-05	0.000143	CcSEcCtD
Budesonide—Hypertension—Epirubicin—breast cancer	1.81e-05	0.000142	CcSEcCtD
Budesonide—Hypersensitivity—Capecitabine—breast cancer	1.81e-05	0.000142	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—breast cancer	1.8e-05	0.000142	CcSEcCtD
Budesonide—Pruritus—Docetaxel—breast cancer	1.79e-05	0.000141	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—breast cancer	1.79e-05	0.000141	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—breast cancer	1.79e-05	0.000141	CcSEcCtD
Budesonide—Myalgia—Epirubicin—breast cancer	1.78e-05	0.000141	CcSEcCtD
Budesonide—Chest pain—Epirubicin—breast cancer	1.78e-05	0.000141	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—breast cancer	1.78e-05	0.000141	CcSEcCtD
Budesonide—Agitation—Doxorubicin—breast cancer	1.78e-05	0.00014	CcSEcCtD
Budesonide—Anxiety—Epirubicin—breast cancer	1.78e-05	0.00014	CcSEcCtD
Budesonide—Nausea—Paclitaxel—breast cancer	1.78e-05	0.00014	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.78e-05	0.000461	CbGpPWpGaD
Budesonide—Skin disorder—Methotrexate—breast cancer	1.77e-05	0.00014	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.77e-05	0.00014	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—breast cancer	1.77e-05	0.000139	CcSEcCtD
Budesonide—Discomfort—Epirubicin—breast cancer	1.76e-05	0.000139	CcSEcCtD
Budesonide—Asthenia—Capecitabine—breast cancer	1.76e-05	0.000139	CcSEcCtD
Budesonide—NR3C1—Gene Expression—RPS7—breast cancer	1.76e-05	0.000456	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS8—breast cancer	1.76e-05	0.000456	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MED12—breast cancer	1.76e-05	0.000456	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.75e-05	0.000455	CbGpPWpGaD
Budesonide—Malaise—Doxorubicin—breast cancer	1.75e-05	0.000138	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—breast cancer	1.74e-05	0.000137	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—breast cancer	1.74e-05	0.000137	CcSEcCtD
Budesonide—Anorexia—Methotrexate—breast cancer	1.74e-05	0.000137	CcSEcCtD
Budesonide—Syncope—Doxorubicin—breast cancer	1.74e-05	0.000137	CcSEcCtD
Budesonide—Pruritus—Capecitabine—breast cancer	1.74e-05	0.000137	CcSEcCtD
Budesonide—Diarrhoea—Docetaxel—breast cancer	1.73e-05	0.000137	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IL6—breast cancer	1.73e-05	0.000449	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.73e-05	0.000448	CbGpPWpGaD
Budesonide—Confusional state—Epirubicin—breast cancer	1.72e-05	0.000136	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—breast cancer	1.71e-05	0.000135	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—breast cancer	1.71e-05	0.000135	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—breast cancer	1.7e-05	0.000134	CcSEcCtD
Budesonide—Infection—Epirubicin—breast cancer	1.7e-05	0.000134	CcSEcCtD
Budesonide—Cough—Doxorubicin—breast cancer	1.69e-05	0.000133	CcSEcCtD
Budesonide—Shock—Epirubicin—breast cancer	1.68e-05	0.000133	CcSEcCtD
Budesonide—Diarrhoea—Capecitabine—breast cancer	1.68e-05	0.000132	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—breast cancer	1.68e-05	0.000132	CcSEcCtD
Budesonide—Dizziness—Docetaxel—breast cancer	1.68e-05	0.000132	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—breast cancer	1.67e-05	0.000132	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—breast cancer	1.67e-05	0.000131	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—breast cancer	1.66e-05	0.000131	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—breast cancer	1.66e-05	0.000131	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—breast cancer	1.65e-05	0.00013	CcSEcCtD
Budesonide—Insomnia—Methotrexate—breast cancer	1.65e-05	0.00013	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—breast cancer	1.65e-05	0.00013	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—breast cancer	1.65e-05	0.00013	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—breast cancer	1.65e-05	0.00013	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—breast cancer	1.64e-05	0.00013	CcSEcCtD
Budesonide—Dexamethasone—ABCB1—breast cancer	1.64e-05	0.00732	CrCbGaD
Budesonide—Paraesthesia—Methotrexate—breast cancer	1.64e-05	0.000129	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.64e-05	0.000129	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—breast cancer	1.63e-05	0.000128	CcSEcCtD
Budesonide—Anorexia—Epirubicin—breast cancer	1.63e-05	0.000128	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—breast cancer	1.63e-05	0.000128	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—COMT—breast cancer	1.63e-05	0.000423	CbGpPWpGaD
Budesonide—Somnolence—Methotrexate—breast cancer	1.62e-05	0.000128	CcSEcCtD
Budesonide—Dizziness—Capecitabine—breast cancer	1.62e-05	0.000128	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.62e-05	0.000421	CbGpPWpGaD
Budesonide—Dry mouth—Doxorubicin—breast cancer	1.61e-05	0.000127	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	1.61e-05	0.000419	CbGpPWpGaD
Budesonide—Vomiting—Docetaxel—breast cancer	1.61e-05	0.000127	CcSEcCtD
Budesonide—Dyspepsia—Methotrexate—breast cancer	1.61e-05	0.000127	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.6e-05	0.000417	CbGpPWpGaD
Budesonide—Rash—Docetaxel—breast cancer	1.6e-05	0.000126	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.6e-05	0.000415	CbGpPWpGaD
Budesonide—Dermatitis—Docetaxel—breast cancer	1.6e-05	0.000126	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—breast cancer	1.59e-05	0.000126	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NOTCH4—breast cancer	1.59e-05	0.000413	CbGpPWpGaD
Budesonide—Decreased appetite—Methotrexate—breast cancer	1.59e-05	0.000125	CcSEcCtD
Budesonide—Headache—Docetaxel—breast cancer	1.59e-05	0.000125	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—breast cancer	1.58e-05	0.000125	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—breast cancer	1.58e-05	0.000124	CcSEcCtD
Budesonide—Fatigue—Methotrexate—breast cancer	1.57e-05	0.000124	CcSEcCtD
Budesonide—Infection—Doxorubicin—breast cancer	1.57e-05	0.000124	CcSEcCtD
Budesonide—Pain—Methotrexate—breast cancer	1.56e-05	0.000123	CcSEcCtD
Budesonide—Vomiting—Capecitabine—breast cancer	1.56e-05	0.000123	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	1.56e-05	0.000405	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Epirubicin—breast cancer	1.56e-05	0.000123	CcSEcCtD
Budesonide—Shock—Doxorubicin—breast cancer	1.56e-05	0.000123	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—breast cancer	1.55e-05	0.000122	CcSEcCtD
Budesonide—Rash—Capecitabine—breast cancer	1.55e-05	0.000122	CcSEcCtD
Budesonide—Insomnia—Epirubicin—breast cancer	1.55e-05	0.000122	CcSEcCtD
Budesonide—Dermatitis—Capecitabine—breast cancer	1.55e-05	0.000122	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—breast cancer	1.54e-05	0.000122	CcSEcCtD
Budesonide—Headache—Capecitabine—breast cancer	1.54e-05	0.000121	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—breast cancer	1.54e-05	0.000121	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—breast cancer	1.53e-05	0.000121	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—breast cancer	1.53e-05	0.00012	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—breast cancer	1.52e-05	0.00012	CcSEcCtD
Budesonide—Somnolence—Epirubicin—breast cancer	1.52e-05	0.00012	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HSPA1B—breast cancer	1.52e-05	0.000394	CbGpPWpGaD
Budesonide—Anorexia—Doxorubicin—breast cancer	1.51e-05	0.000119	CcSEcCtD
Budesonide—Nausea—Docetaxel—breast cancer	1.51e-05	0.000119	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—breast cancer	1.51e-05	0.000119	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—breast cancer	1.5e-05	0.000119	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—breast cancer	1.49e-05	0.000118	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	1.49e-05	0.000388	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.49e-05	0.000387	CbGpPWpGaD
Budesonide—Decreased appetite—Epirubicin—breast cancer	1.49e-05	0.000117	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—breast cancer	1.48e-05	0.000116	CcSEcCtD
Budesonide—Fatigue—Epirubicin—breast cancer	1.47e-05	0.000116	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.47e-05	0.000381	CbGpPWpGaD
Budesonide—Pain—Epirubicin—breast cancer	1.46e-05	0.000115	CcSEcCtD
Budesonide—Constipation—Epirubicin—breast cancer	1.46e-05	0.000115	CcSEcCtD
Budesonide—Nausea—Capecitabine—breast cancer	1.46e-05	0.000115	CcSEcCtD
Budesonide—NR3C1—Gene Expression—PGR—breast cancer	1.45e-05	0.000378	CbGpPWpGaD
Budesonide—Urticaria—Methotrexate—breast cancer	1.45e-05	0.000114	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—breast cancer	1.44e-05	0.000114	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—breast cancer	1.44e-05	0.000114	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.44e-05	0.000114	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—breast cancer	1.43e-05	0.000113	CcSEcCtD
Budesonide—NR3C1—Gene Expression—DNMT1—breast cancer	1.43e-05	0.000371	CbGpPWpGaD
Budesonide—Paraesthesia—Doxorubicin—breast cancer	1.42e-05	0.000112	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.41e-05	0.000367	CbGpPWpGaD
Budesonide—Dyspnoea—Doxorubicin—breast cancer	1.41e-05	0.000111	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—breast cancer	1.41e-05	0.000111	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—breast cancer	1.41e-05	0.000111	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NCOA2—breast cancer	1.4e-05	0.000364	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Epirubicin—breast cancer	1.4e-05	0.00011	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—breast cancer	1.39e-05	0.00011	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.39e-05	0.000362	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—EZH2—breast cancer	1.38e-05	0.000359	CbGpPWpGaD
Budesonide—Decreased appetite—Doxorubicin—breast cancer	1.37e-05	0.000108	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—breast cancer	1.37e-05	0.000108	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—breast cancer	1.36e-05	0.000107	CcSEcCtD
Budesonide—Urticaria—Epirubicin—breast cancer	1.36e-05	0.000107	CcSEcCtD
Budesonide—Pain—Doxorubicin—breast cancer	1.35e-05	0.000107	CcSEcCtD
Budesonide—Constipation—Doxorubicin—breast cancer	1.35e-05	0.000107	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NOTCH3—breast cancer	1.35e-05	0.000351	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PARP1—breast cancer	1.35e-05	0.000351	CbGpPWpGaD
Budesonide—Body temperature increased—Epirubicin—breast cancer	1.35e-05	0.000106	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—breast cancer	1.35e-05	0.000106	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—breast cancer	1.35e-05	0.000106	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	1.33e-05	0.000345	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS6—breast cancer	1.32e-05	0.000343	CbGpPWpGaD
Budesonide—Asthenia—Methotrexate—breast cancer	1.31e-05	0.000103	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—breast cancer	1.3e-05	0.000103	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—breast cancer	1.29e-05	0.000102	CcSEcCtD
Budesonide—Pruritus—Methotrexate—breast cancer	1.29e-05	0.000102	CcSEcCtD
Budesonide—NR3C1—Gene Expression—ESR2—breast cancer	1.28e-05	0.000333	CbGpPWpGaD
Budesonide—Hypersensitivity—Epirubicin—breast cancer	1.26e-05	9.92e-05	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—breast cancer	1.26e-05	9.9e-05	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—breast cancer	1.25e-05	9.85e-05	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—breast cancer	1.25e-05	9.85e-05	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—breast cancer	1.25e-05	9.85e-05	CcSEcCtD
Budesonide—Asthenia—Epirubicin—breast cancer	1.23e-05	9.66e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NOTCH2—breast cancer	1.21e-05	0.000315	CbGpPWpGaD
Budesonide—Pruritus—Epirubicin—breast cancer	1.21e-05	9.53e-05	CcSEcCtD
Budesonide—Dizziness—Methotrexate—breast cancer	1.21e-05	9.52e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NCOA1—breast cancer	1.18e-05	0.000307	CbGpPWpGaD
Budesonide—Diarrhoea—Epirubicin—breast cancer	1.17e-05	9.22e-05	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—breast cancer	1.17e-05	9.18e-05	CcSEcCtD
Budesonide—Vomiting—Methotrexate—breast cancer	1.16e-05	9.15e-05	CcSEcCtD
Budesonide—Rash—Methotrexate—breast cancer	1.15e-05	9.08e-05	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—breast cancer	1.15e-05	9.07e-05	CcSEcCtD
Budesonide—Headache—Methotrexate—breast cancer	1.14e-05	9.02e-05	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—breast cancer	1.13e-05	8.94e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.13e-05	0.000295	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AR—breast cancer	1.13e-05	0.000294	CbGpPWpGaD
Budesonide—Dizziness—Epirubicin—breast cancer	1.13e-05	8.91e-05	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—breast cancer	1.12e-05	8.82e-05	CcSEcCtD
Budesonide—Vomiting—Epirubicin—breast cancer	1.09e-05	8.56e-05	CcSEcCtD
Budesonide—Nausea—Methotrexate—breast cancer	1.08e-05	8.55e-05	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—breast cancer	1.08e-05	8.53e-05	CcSEcCtD
Budesonide—Rash—Epirubicin—breast cancer	1.08e-05	8.49e-05	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—breast cancer	1.08e-05	8.49e-05	CcSEcCtD
Budesonide—Headache—Epirubicin—breast cancer	1.07e-05	8.44e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—NDUFS3—breast cancer	1.05e-05	0.000274	CbGpPWpGaD
Budesonide—Dizziness—Doxorubicin—breast cancer	1.05e-05	8.24e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—SIRT1—breast cancer	1.03e-05	0.000268	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SMAD4—breast cancer	1.02e-05	0.000265	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—VDR—breast cancer	1.02e-05	0.000264	CbGpPWpGaD
Budesonide—Nausea—Epirubicin—breast cancer	1.02e-05	8e-05	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—breast cancer	1.01e-05	7.92e-05	CcSEcCtD
Budesonide—Rash—Doxorubicin—breast cancer	9.97e-06	7.86e-05	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—breast cancer	9.96e-06	7.85e-05	CcSEcCtD
Budesonide—CYP3A4—Metabolism—CHST9—breast cancer	9.92e-06	0.000258	CbGpPWpGaD
Budesonide—Headache—Doxorubicin—breast cancer	9.91e-06	7.81e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NCOR1—breast cancer	9.89e-06	0.000257	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—H2AFX—breast cancer	9.63e-06	0.00025	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COX11—breast cancer	9.4e-06	0.000244	CbGpPWpGaD
Budesonide—Nausea—Doxorubicin—breast cancer	9.39e-06	7.4e-05	CcSEcCtD
Budesonide—NR3C1—Gene Expression—ERCC2—breast cancer	9.29e-06	0.000242	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SHMT1—breast cancer	8.6e-06	0.000223	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CDA—breast cancer	8.6e-06	0.000223	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	8.39e-06	0.000218	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A5—breast cancer	8.28e-06	0.000215	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLCO1B1—breast cancer	8.28e-06	0.000215	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APRT—breast cancer	7.99e-06	0.000208	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR1—breast cancer	7.77e-06	0.000202	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ESRRA—breast cancer	7.52e-06	0.000195	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ANGPTL4—breast cancer	7.52e-06	0.000195	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NOTCH1—breast cancer	7.51e-06	0.000195	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HADHB—breast cancer	7.13e-06	0.000185	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPI—breast cancer	7.13e-06	0.000185	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.8e-06	0.000177	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.8e-06	0.000177	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PHGDH—breast cancer	6.52e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADSL—breast cancer	6.52e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NME1—breast cancer	6.52e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UMPS—breast cancer	6.52e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FHL2—breast cancer	6.52e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LDHB—breast cancer	6.39e-06	0.000166	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BRIP1—breast cancer	6.39e-06	0.000166	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HPSE—breast cancer	6.39e-06	0.000166	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—breast cancer	6.38e-06	0.000166	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCC1—breast cancer	6.06e-06	0.000157	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA3—breast cancer	6.06e-06	0.000157	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMMR—breast cancer	6.06e-06	0.000157	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.87e-06	0.000152	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA9—breast cancer	5.54e-06	0.000144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA4—breast cancer	5.54e-06	0.000144	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA2—breast cancer	5.4e-06	0.00014	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX2—breast cancer	5.4e-06	0.00014	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT1A1—breast cancer	5.33e-06	0.000139	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX4—breast cancer	5.33e-06	0.000139	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA1—breast cancer	5.21e-06	0.000135	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—IDH1—breast cancer	5.21e-06	0.000135	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAT2—breast cancer	5.15e-06	0.000134	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DPYD—breast cancer	4.52e-06	0.000117	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MED12—breast cancer	4.52e-06	0.000117	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDOA—breast cancer	4.45e-06	0.000116	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA3—breast cancer	4.32e-06	0.000112	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A2—breast cancer	4.29e-06	0.000111	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG2—breast cancer	4.2e-06	0.000109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTR—breast cancer	4.2e-06	0.000109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CPT1A—breast cancer	4.2e-06	0.000109	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—breast cancer	4.15e-06	0.000108	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HPGDS—breast cancer	4.12e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HBA1—breast cancer	4.09e-06	0.000106	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—breast cancer	4.04e-06	0.000105	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—breast cancer	3.99e-06	0.000104	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACHE—breast cancer	3.99e-06	0.000104	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP17A1—breast cancer	3.78e-06	9.83e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENO1—breast cancer	3.74e-06	9.73e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS1—breast cancer	3.74e-06	9.73e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2D6—breast cancer	3.67e-06	9.54e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA2—breast cancer	3.6e-06	9.36e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FASN—breast cancer	3.49e-06	9.08e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BCHE—breast cancer	3.48e-06	9.04e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A5—breast cancer	3.44e-06	8.93e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A1—breast cancer	3.32e-06	8.63e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NQO1—breast cancer	3.32e-06	8.63e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1B1—breast cancer	3.18e-06	8.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.12e-06	8.11e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA1—breast cancer	3.04e-06	7.89e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STK11—breast cancer	2.99e-06	7.78e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP19A1—breast cancer	2.99e-06	7.78e-05	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—breast cancer	2.8e-06	7.28e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COMT—breast cancer	2.78e-06	7.23e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—breast cancer	2.77e-06	7.2e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—breast cancer	2.73e-06	7.1e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ITPR1—breast cancer	2.72e-06	7.08e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCB1—breast cancer	2.62e-06	6.81e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TYMS—breast cancer	2.57e-06	6.69e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOR1—breast cancer	2.54e-06	6.61e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.54e-06	6.61e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—breast cancer	2.54e-06	6.61e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX1—breast cancer	2.44e-06	6.33e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A1—breast cancer	2.41e-06	6.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ERCC2—breast cancer	2.39e-06	6.22e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—breast cancer	2.25e-06	5.84e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAV1—breast cancer	2.07e-06	5.39e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.89e-06	4.91e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.66e-06	4.32e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—breast cancer	1.64e-06	4.26e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—breast cancer	1.57e-06	4.08e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.45e-06	3.76e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—breast cancer	1.43e-06	3.73e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTEN—breast cancer	1.25e-06	3.25e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—breast cancer	8.82e-07	2.29e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—breast cancer	7.21e-07	1.87e-05	CbGpPWpGaD
